People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Diceros Therapeutics, Inc. | — | Biotechnology | Series A | $12.6M | $156.3M | 2022 |
| AesRx, LLC | — | Biotechnology | Seed | $8.1M | $26.6M | 2011 |
Stephen R. Seiler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen R. Seiler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mary K Pendergast | 1 | 2 |
| Maggie Flanagan LeFlore | 1 | 1 |
| Ids R. Van Der Weij | 1 | 1 |
| Wyatt R. Gotbetter | 1 | 1 |
| Jonathan R. Fleming | 1 | 1 |
| Maggie R. LeFlore | 1 | 1 |
| Colin R. Hill | 1 | 1 |
| R. John K. Fletcher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.